Phathom Pharmaceuticals

Share on: 

Phathom Pharmaceuticals is developing solutions for people suffering from acid-related gastrointestinal (GI) disorders. Phathom’s lead clinical candidate, vonoprazan, is a potassium-competitive acid blocker (P-CAB), a novel class of medicines with the potential to address multiple unmet needs in GI medicine.

Career Page(s): 
Menlo Park CA
United States